Brokowski Carolyn
Department of Emergency Medicine, Yale School of Medicine , New Haven, Connecticut.
CRISPR J. 2018 Apr;1(2):115-125. doi: 10.1089/crispr.2017.0024.
The extraordinary wave of genomic-engineering innovation, driven by CRISPR-Cas9, has sparked worldwide scientific and ethical uncertainty. Great concern has arisen across the globe about whether heritable genome editing should be permissible in humans-that is, whether it is morally acceptable to modify genomic material such that the "edit" is transferable to future generations. Here I examine 61 ethics statements released by the international community within the past 3 years about this controversial issue and consider the statements' overarching positions and limitations. Despite their inability to fully address all important considerations, many of the statements may advance debate and national and international law and public policy.
由CRISPR-Cas9驱动的基因组工程创新浪潮引发了全球范围内的科学和伦理不确定性。全球范围内人们高度关注可遗传的基因组编辑在人类中是否应被允许,也就是说,修改基因组物质以使“编辑”能够传递给后代在道德上是否可接受。在此,我审视了国际社会在过去三年里就这一有争议问题发布的61份伦理声明,并考量了这些声明的总体立场和局限性。尽管它们无法全面涵盖所有重要考量因素,但许多声明可能会推动相关辩论以及国家和国际法及公共政策的发展。